Am J Physiol Cell Physiol Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 293: C1278-C1285, 2007. First published July 25, 2007; doi:10.1152/ajpcell.00201.2007
0363-6143/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/C1278    most recent
00201.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiPasquale, D. M.
Right arrow Articles by Koh, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiPasquale, D. M.
Right arrow Articles by Koh, T. J.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice

Dana M. DiPasquale,1 Ming Cheng,1 William Billich,1 Sharon A. Huang,2 Nico van Rooijen,3 Troy A. Hornberger,2 and Timothy J. Koh1

1Department of Movement Sciences, University of Illinois, Chicago, Illinois; 2Department of Bioengineering, University of California, San Diego, California; and 3Department of Cell Biology, Vrije Universiteit, Amsterdam, The Netherlands

Submitted 16 May 2007 ; accepted in final form 19 July 2007

Adult skeletal muscle possesses remarkable potential for growth in response to mechanical loading; however, many of the cellular and molecular mechanisms involved remain undefined. The hypothesis of this study was that the extracellular serine protease, urokinase-type plasminogen activator (uPA), is required for muscle hypertrophy, in part by promoting macrophage accumulation in muscle subjected to increased mechanical loading. Compensatory muscle hypertrophy was induced in mouse plantaris (PLT) muscles by surgical ablation of synergist muscles. Following synergist ablation, PLT muscles in wild-type mice demonstrated edema and infiltration of neutrophils and macrophages but an absence of overt muscle fiber damage. Sham procedures resulted in no edema or accumulation of inflammatory cells. In addition, synergist ablation was associated with a large increase in activity of uPA in the PLT muscle. uPA-null mice demonstrated complete abrogation of compensatory hypertrophy associated with reduced macrophage accumulation, indicating that uPA is required for hypertrophy. Macrophages isolated from wild-type PLT muscle during compensatory hypertrophy expressed uPA and IGF-I, both of which may contribute to hypertrophy. To determine whether macrophages are required for muscle hypertrophy, clodronate liposomes were administered to deplete macrophages in wild-type mice; this resulted in reduced muscle hypertrophy. Decreased macrophage accumulation was associated with reduced cell proliferation but did not alter signaling through the mammalian target of rapamycin pathway. These data indicate that uPA and macrophages are required for muscle hypertrophy following synergist ablation.

skeletal muscle growth; inflammation; plasminogen system


Address for reprint requests and other correspondence: T. J. Koh, Dept. of Movement Sciences, Univ. of Illinois at Chicago, 1919 W. Taylor, Rm. 529 m/c 994, Chicago, IL 60612 (e-mail: tjkoh{at}uic.edu)




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
V. Varma, A. Yao-Borengasser, N. Rasouli, G. T. Nolen, B. Phanavanh, T. Starks, C. Gurley, P. Simpson, R. E. McGehee Jr., P. A. Kern, et al.
Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1300 - E1310.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. L Novak, W. Billich, S. M. Smith, K. B. Sukhija, T. J. McLoughlin, T. A. Hornberger, and T. J. Koh
COX-2 inhibitor reduces skeletal muscle hypertrophy in mice
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1132 - R1139.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
F. X. Pizza, B. C. Clark, R. E. De Meersman, S. M. Phillips, N. Stupka, S. Sipila, V. Kovanen, H. Suominen, G. L. Warren, D. A. Lowe, et al.
Comments on Point:Counterpoint: Estrogen and sex do/do not influence post-exercise indexes of muscle damage, inflammation, and repair
J Appl Physiol, March 1, 2009; 106(3): 1016 - 1020.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. S. Marino, B. J. Tausch, C. L. Dearth, M. V. Manacci, T. J. McLoughlin, S. J. Rakyta, M. P. Linsenmayer, and F. X. Pizza
{beta}2-Integrins contribute to skeletal muscle hypertrophy in mice
Am J Physiol Cell Physiol, October 1, 2008; 295(4): C1026 - C1036.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.